Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-04 4:15 pm Purchase | 13G | Cidara Therapeutics Inc. CDTX | Venrock Healthcare Capital Partners III L.P. | 1,129,097 9.990% | 1,129,097 (New Position) | View |
| 2024-11-14 5:52 pm Purchase | 13G | Zura Bio Ltd ZURA | Venrock Healthcare Capital Partners III L.P. | 6,853,600 9.990% | 453,981 (+7.09%) | View |
| 2024-11-14 5:52 pm Sale | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Venrock Healthcare Capital Partners III L.P. | 3,575,309 5.500% | -1,980,259 (-35.64%) | View |
| 2024-11-14 5:51 pm Sale | 13G | Terns Pharmaceuticals Inc. TERN | Venrock Healthcare Capital Partners III L.P. | 3,516,889 4.990% | -980,228 (-21.80%) | View |
| 2024-11-14 5:51 pm Sale | 13G | TAYSHA GENE THERAPIES INC TSHA | Venrock Healthcare Capital Partners III L.P. | 9,000,000 4.400% | -1,412,872 (-13.57%) | View |
| 2024-11-14 5:50 pm Sale | 13G | SPYRE THERAPEUTICS, INC SYRE | Venrock Healthcare Capital Partners III L.P. | 2,685,448 5.300% | -1,049,066 (-28.09%) | View |
| 2024-11-14 5:50 pm Purchase | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Venrock Healthcare Capital Partners III L.P. | 906,486 5.000% | 82,860 (+10.06%) | View |
| 2024-11-14 5:49 pm Purchase | 13G | ORUKA THERAPEUTICS INC ORKA | Venrock Healthcare Capital Partners III L.P. | 3,541,941 9.990% | 3,541,941 (New Position) | View |
| 2024-11-14 5:49 pm Purchase | 13G | OCULAR THERAPEUTIX INC OCUL | Venrock Healthcare Capital Partners III L.P. | 13,760,200 8.700% | 5,984,440 (+76.96%) | View |
| 2024-11-14 5:48 pm Purchase | 13G | Enliven Therapeutics Inc. ELVN | Venrock Healthcare Capital Partners III L.P. | 4,026,331 8.500% | 1,071,429 (+36.26%) | View |
| 2024-11-14 5:48 pm Purchase | 13G | ENGENE HLDGS INC ENGN | Venrock Healthcare Capital Partners III L.P. | 3,565,841 8.100% | 1,000,000 (+38.97%) | View |
| 2024-11-14 5:47 pm Purchase | 13G | Applied Therapeutics Inc. APLT | Venrock Healthcare Capital Partners III L.P. | 11,656,065 9.990% | 3,778,248 (+47.96%) | View |
| 2024-11-14 5:47 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | Venrock Healthcare Capital Partners III L.P. | 1,744,373 5.900% | 816,667 (+88.03%) | View |
| 2024-11-14 5:46 pm Sale | 13G | CABALETTA BIO INC CABA | Venrock Healthcare Capital Partners III L.P. | 1,590,696 3.300% | -973,256 (-37.96%) | View |
| 2024-11-14 5:46 pm Purchase | 13G | Century Therapeutics Inc. IPSC | Venrock Healthcare Capital Partners III L.P. | 5,389,259 6.400% | 1,984,126 (+58.27%) | View |
| 2024-11-14 5:46 pm Sale | 13G | Celcuity Inc. CELC | Venrock Healthcare Capital Partners III L.P. | 0 0.000% | -2,476,980 (Position Closed) | View |
| 2024-11-14 5:45 pm Purchase | 13G | ASTRIA THERAPEUTICS INC ATXS | Venrock Healthcare Capital Partners III L.P. | 3,458,645 6.100% | 232,839 (+7.22%) | View |
| 2024-08-19 4:15 pm Purchase | 13G | TENAX THERAPEUTICS INC. TENX | Venrock Healthcare Capital Partners III L.P. | 355,224 9.990% | 355,224 (New Position) | View |
| 2024-08-01 4:18 pm Purchase | 13G | ARTIVA BIOTHERAPEUTICS INC ARTV | Venrock Healthcare Capital Partners III L.P. | 1,609,569 6.900% | 1,609,569 (New Position) | View |
| 2024-07-25 8:48 pm Purchase | 13G | CASI PHARMACEUTICALS HLDGS INC CASI | Venrock Healthcare Capital Partners III L.P. | 1,507,040 9.990% | 1,507,040 (New Position) | View |